Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise Reports (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Barrick Revises Outlook but May Have Bottomed

% of readers think this story is Fact. Add your two cents.


Source: Adrian Day 12/12/2024

Global Analyst Adrian Day reviews forecasts and developments at companies on his list.

Barrick Gold Corp.’s (ABX:TSX; GOLD:NYSE) latest 5-year projections show gold production recovering from 2024′s expected 3.9M ounces to 4.7M ounces by 2029, though down from 5.5M post-merger levels.

Copper production is set to double through Ghana and Pakistan expansions despite higher Reko Diq capital requirements. More conservative guidance could rebuild investor confidence after consistent target misses.

The situation in Mali remains tense with four employees detained amid $417M tax dispute. However, the stock trades at 0.6x NAV versus peer average of 1x and remains cheap with a formidable balance sheet. Not enough institutions own it.

Buy.

Nestlé Outlines Cost-Focused Strategy

Nestle SA’s (NESN:VX; NSRGY:OTC) management presented cost-saving initiatives and a 9% sales allocation to marketing. Water and premium beverages will become standalone divisions.

The focus will be on turning around U.S. frozen foods and Health Science units.

The stock has been down 40% since 2022 and now yields 3.9% — the highest in 30 years. Dividend growth has been maintained since 1996.

I consider it undervalued, and we will accumulate at these levels and perhaps become more aggressive in the future.

Fox River Gains Strategic Investor

Fox River Resources Corp. (FOX:CNSX) reported that an unnamed investor acquired a 9.9% stake through a CA$0.40 private placement, adding CA$2.9M to advance the Martison Phosphate Project.

We are optimistic about this development as it gives further validation for the company, while also adding to the company’s treasury.

Currently, the stock is thinly traded, so we suggest you don’t chase it.

Orogen Reports Revenue Growth

Orogen Royalties Inc.’s (OGN:TSX.V) announced that its Ermitaño royalty revenue was up to $2.1M from $1.6M year-over-year.

The operating cash flow increased to $948,000 from $715,000. However, net income lowered from write-downs.

The operator of the mine, First Majestic Silver Corp. (FR:TSX; AG:NYSE; FMV:FSE) has been exploring the royalty land.

Buy on upcoming weakness.

Lara Exploration Strengthens Treasury

Lara Exploration Ltd. (LRA:TSX.V) raised a little over CA$3M through warrant exercise.

This brought its cash to CA$5.6M.

The company is currently well-positioned to advance its Planalto copper project, with incoming revenue from the recently resumed Celesta copper project.

While in a good position to advance the Planalto copper project, Lara is a Buy.

Franco-Nevada Sees Hope for Cobre Restart

Franco-Nevada Corp. (FNV:TSX; FNV:NYSE) reported that Panama’s president signaled an early 2024 focus on reopening the Cobre mine after an environmental audit. This audit would address the public’s concerns.

The mine previously contributed 19% of Franco’s revenue. The current valuation assumes zero Cobre value, presenting upside potential.

Franco-Nevada has a strong balance sheet with $1.4 billion in cash. The company is solid.

Buy.

TOP BUYS this week include Kingsmen Creatives Ltd. (KMEN:SI), Pan American Silver Corp. (PAAS:TSX; PAAS:NASDAQ), and Metalla Royalty & Streaming Ltd. (MTA:TSX.V; MTA:NYSE American).

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Important Disclosures:

  1. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Barrick Gold Corp., Fox Riv Res Corp., Orogen Royalties Inc., Lara Exploration Ltd., Franco-Nevada Corp., Pan American Silver Corp., and Metalla Royalty & Streaming.
  2. Adrian Day: I, or members of my immediate household or family, own securities of: All. My company has a financial relationship with: All. I determined which companies would be included in this article based on my research and understanding of the sector.
  3. Statements and opinions expressed are the opinions of the author and not of Streetwise Reports, Street Smart, or their officers. The author is wholly responsible for the accuracy of the statements. Streetwise Reports was not paid by the author to publish or syndicate this article. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Any disclosures from the author can be found below. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
  4. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

Adrian Day Disclosures

Adrian Day’s Global Analyst is distributed for $990 per year by Investment Consultants International, Ltd., P.O. Box 6644, Annapolis, MD 21401. (410) 224-8885. www.AdrianDayGlobalAnalyst.com. Publisher: Adrian Day. Owner: Investment Consultants International, Ltd. Staff may have positions in securities discussed herein. Adrian Day is also President of Global Strategic Management (GSM), a registered investment advisor, and a separate company from this service. In his capacity as GSM president, Adrian Day may be buying or selling for clients securities recommended herein concurrently, before or after recommendations herein, and may be acting for clients in a manner contrary to recommendations herein. This is not a solicitation for GSM. Views herein are the editor’s opinion and not fact. All information is believed to be correct, but its accuracy cannot be guaranteed. The owner and editor are not responsible for errors and omissions. © 2023. Adrian Day’s Global Analyst. Information and advice herein are intended purely for the subscriber’s own account. Under no circumstances may any part of a Global Analyst e-mail be copied or distributed without prior written permission of the editor. Given the nature of this service, we will pursue any violations aggressively.

( Companies Mentioned: ABX:TSX; GOLD:NYSE, FOX:CNSX, FNV:TSX; FNV:NYSE, LRA:TSX.V, NESN:VX; NSRGY:OTC, OGN:TSX.V, )


Source: https://www.streetwisereports.com/article/2024/12/12/barrick-revises-outlook-but-may-have-bottomed.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.